Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.26 USD | -2.41% | -8.04% | -41.49% |
Business Summary
Number of employees: 380
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Tiopronin Products
77.1
%
| 98 | 48.9 % | 98 | 77.1 % | +0.37% |
FILSPARI
22.9
%
| - | - | 29 | 22.9 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 201 | 100.0 % | 128 | 100.0 % | -36.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eric Dube
CEO | Chief Executive Officer | 51 | 03/01/19 |
Chris Cline
DFI | Director of Finance/CFO | 40 | 31/07/14 |
Jula Inrig
CTO | Chief Tech/Sci/R&D Officer | 49 | 03/01/22 |
Bill Rote
CTO | Chief Tech/Sci/R&D Officer | 61 | 31/01/17 |
Naomi Eichenbaum
IRC | Investor Relations Contact | - | - |
Human Resources Officer | - | - | |
Sandra Calvin
AUD | Comptroller/Controller/Auditor | 59 | 30/11/14 |
Peter Heerma
PRN | Corporate Officer/Principal | 53 | 30/09/19 |
Casey H. Logan
PRN | Corporate Officer/Principal | 52 | 04/03/18 |
Elizabeth Reed
LAW | General Counsel | 53 | 03/01/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Coughlin
BRD | Director/Board Member | 57 | 30/03/15 |
Jeffrey Meckler
BRD | Director/Board Member | 57 | 07/10/14 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 07/04/20 |
Gary Lyons
CHM | Chairman | 73 | 08/10/14 |
Roy Baynes
BRD | Director/Board Member | 69 | 30/06/16 |
John Orwin
BRD | Director/Board Member | 59 | 22/03/17 |
Ron Squarer
BRD | Director/Board Member | 57 | 11/04/17 |
Sandra E. Poole
BRD | Director/Board Member | 60 | 12/05/19 |
Eric Dube
CEO | Chief Executive Officer | 51 | 03/01/19 |
Sandra Calvin
AUD | Comptroller/Controller/Auditor | 59 | 30/11/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,108,829 | 75,201,296 ( 98.81 %) | 0 | 98.81 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.49% | 400M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- TVTX Stock
- Company Travere Therapeutics, Inc.